{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:31:42Z","timestamp":1782570702839,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":559,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41379-021-00776-z","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T07:03:58Z","timestamp":1614927838000},"page":"1384-1391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5293","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristos Z.","family":"Kaimakliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00776-z_bib1","series-title":"Bladder Pathology","author":"Cheng","year":"2012"},{"key":"10.1038\/s41379-021-00776-z_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2559.2010.03651.x","article-title":"Glandular lesions of the urinary bladder: clinical significance and differential diagnosis","volume":"58","author":"Williamson","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00776-z_bib3","doi-asserted-by":"crossref","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumours of the urinary system and male genital organ. (International Agency for Research on Cancer (IARC): Lyon, France, IARC Press, 2016.","DOI":"10.1016\/j.eururo.2016.02.028"},{"key":"10.1038\/s41379-021-00776-z_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1541-7786.MCR-16-0003","article-title":"Understanding TERT promoter mutations: a common path to immortality","volume":"14","author":"Bell","year":"2016","journal-title":"Mol Cancer Res"},{"key":"10.1038\/s41379-021-00776-z_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome","volume":"65","author":"Allory","year":"2014","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00776-z_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41585-018-0001-5","article-title":"Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis","volume":"15","author":"Gunes","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1038\/s41379-021-00776-z_bib7","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/PAS.0000000000001453","article-title":"Report from the International Society of Urological Pathology (ISUP) Consultation Conference on molecular pathology of urogenital cancers. II. Molecular pathology of bladder cancer: progress and challenges","volume":"44","author":"Warrick","year":"2020","journal-title":"Am J Surg Pathol."},{"key":"10.1038\/s41379-021-00776-z_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00776-z_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/his.14038","article-title":"The expanding molecular and mutational landscape of nested variant of urothelial carcinoma","volume":"76","author":"Levy","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00776-z_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/his.12920","article-title":"Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change","volume":"69","author":"Cheng","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00776-z_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2217\/fon-2016-0414","article-title":"TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract","volume":"13","author":"Wang","year":"2017","journal-title":"Future Oncol"},{"key":"10.1038\/s41379-021-00776-z_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eururo.2016.12.008","article-title":"TERT promoter mutations occur frequently in urothelial papilloma and papillary urothelial neoplasm of low malignant potential","volume":"71","author":"Cheng","year":"2017","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00776-z_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1365-2559.2012.04309.x","article-title":"KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas","volume":"61","author":"Alexander","year":"2012","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00776-z_bib14","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0022-5347(06)00317-X","article-title":"Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder","volume":"175","author":"Rogers","year":"2006","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00776-z_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.urolonc.2005.05.027","article-title":"Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients","volume":"24","author":"Zaghloul","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1038\/s41379-021-00776-z_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.humpath.2006.05.009","article-title":"Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications","volume":"37","author":"Lopez-Beltran","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib17","series-title":"Molecular Surgical Pathology","author":"Cheng","year":"2013"},{"key":"10.1038\/s41379-021-00776-z_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.humpath.2010.07.007","article-title":"Bladder cancer: translating molecular genetic insights into clinical practice","volume":"42","author":"Cheng","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.eururo.2013.08.057","article-title":"Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine","volume":"65","author":"Hurst","year":"2014","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00776-z_bib20","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1158\/0008-5472.CAN-13-2498","article-title":"TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine","volume":"73","author":"Kinde","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-021-00776-z_bib21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aao0535","article-title":"Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism","volume":"357","author":"Chiba","year":"2017","journal-title":"Science"},{"key":"10.1038\/s41379-021-00776-z_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.anndiagpath.2015.12.002","article-title":"Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications","volume":"21","author":"Kurtis","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0000000000000305","article-title":"Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation","volume":"39","author":"Zhong","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00428-020-02787-8","article-title":"Comparative genomic profiling of glandular bladder tumours","volume":"477","author":"Maurer","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00776-z_bib25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41379-020-0453-z","article-title":"PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates","volume":"33","author":"Taylor","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib26","doi-asserted-by":"crossref","unstructured":"Acosta AM, Sholl LM, Fanelli GN, Gordetsky JB, Baniak N, Barletta JA, et al. Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants. Mod Pathol. 2020 https:\/\/doi.org\/10.1038\/s41379-020-00655-z","DOI":"10.1038\/s41379-020-00655-z"},{"key":"10.1038\/s41379-021-00776-z_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.5307","article-title":"Distinct mutational landscape of inverted urothelial papilloma","volume":"249","author":"Akgul","year":"2019","journal-title":"J Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2016.53","article-title":"High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder","volume":"29","author":"Cowan","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2016.02.009","article-title":"Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder","volume":"53","author":"Cowan","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/path.5261","article-title":"Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder","volume":"248","author":"Isharwal","year":"2019","journal-title":"J Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41379-020-0453-z","article-title":"PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates","volume":"33","author":"Taylor","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.anndiagpath.2015.06.007","article-title":"Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder","volume":"19","author":"Vail","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/s41379-021-00776-z_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/his.13958","article-title":"Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma","volume":"75","author":"Weyerer","year":"2019","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00776-z_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pin.12594","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer","volume":"67","author":"Thiem","year":"2017","journal-title":"Pathol Int"},{"key":"10.1038\/s41379-021-00776-z_bib35","unstructured":"Cheng L, MacLennan GT, Bostwick DG. Urologic Surgical Pathology. 4th ed. Philadelphia, PA: Elsevier; 2020."},{"key":"10.1038\/s41379-021-00776-z_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000381903","article-title":"Frequency of TERT promoter mutations in prostate cancer","volume":"82","author":"Stoehr","year":"2015","journal-title":"Pathobiology"},{"key":"10.1038\/s41379-021-00776-z_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/1678-4685-gmb-2017-0133","article-title":"Absence of TERT promoter mutations in colorectal precursor lesions and cancer","volume":"41","author":"Cruvinel-Carloni","year":"2018","journal-title":"Genet Mol Biol"},{"key":"10.1038\/s41379-021-00776-z_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.euf.2017.03.007","article-title":"Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutation status differentiates sites of malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma.","volume":"4","author":"Priemer","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1038\/s41379-021-00776-z_bib39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.18632\/oncotarget.1829","article-title":"TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-021-00776-z_bib40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2013.10.038","article-title":"Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study","volume":"65","author":"Wu","year":"2014","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00776-z_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/his.13318","article-title":"Comparative study of TERT promoter mutation status within spatially, temporally and morphologically distinct components of urothelial carcinoma","volume":"72","author":"Brown","year":"2018","journal-title":"Histopathology"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00776-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00776-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-021-00776-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:37:34Z","timestamp":1760229454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0893395222005890"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00776-z","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00776-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}